Log in
NASDAQ:ETNB

89bio News Headlines

$25.36
+0.94 (+3.85 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$24.47
Now: $25.36
$26.00
50-Day Range
$24.34
MA: $32.82
$38.82
52-Week Range
$14.00
Now: $25.36
$47.25
Volume350,550 shs
Average Volume91,764 shs
Market Capitalization$427.42 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

89bio (NASDAQ ETNB) News Headlines Today

Source:
DateHeadline
89bio (NASDAQ:ETNB) Raised to Buy at Bank of America89bio (NASDAQ:ETNB) Raised to Buy at Bank of America
americanbankingnews.com - September 25 at 10:45 AM
89bio (NASDAQ:ETNB) Rating Increased to Buy at BofA Securities89bio (NASDAQ:ETNB) Rating Increased to Buy at BofA Securities
americanbankingnews.com - September 25 at 9:57 AM
Orbimed Advisors Llc Sells 275,000 Shares of 89bio (NASDAQ:ETNB) StockOrbimed Advisors Llc Sells 275,000 Shares of 89bio (NASDAQ:ETNB) Stock
americanbankingnews.com - September 23 at 9:30 PM
89bio (NASDAQ:ETNB) Director Ra Capital Management, L.P. Acquires 1,300,000 Shares89bio (NASDAQ:ETNB) Director Ra Capital Management, L.P. Acquires 1,300,000 Shares
americanbankingnews.com - September 21 at 6:51 PM
89bio (NASDAQ:ETNB) Given Average Rating of "Buy" by Brokerages89bio (NASDAQ:ETNB) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - September 20 at 8:28 AM
89bio (NASDAQ:ETNB) Trading Down 14.7%89bio (NASDAQ:ETNB) Trading Down 14.7%
americanbankingnews.com - September 17 at 8:52 PM
89bio (NASDAQ:ETNB) Short Interest Update89bio (NASDAQ:ETNB) Short Interest Update
americanbankingnews.com - September 17 at 8:11 AM
89bio prices upsized equity offering at $2889bio prices upsized equity offering at $28
seekingalpha.com - September 17 at 1:45 AM
89bio (NASDAQ:ETNB) Price Target Increased to $58.00 by Analysts at BTIG Research89bio (NASDAQ:ETNB) Price Target Increased to $58.00 by Analysts at BTIG Research
americanbankingnews.com - September 15 at 9:11 AM
89bio (NASDAQ:ETNB) PT Raised to $95.0089bio (NASDAQ:ETNB) PT Raised to $95.00
americanbankingnews.com - September 15 at 8:28 AM
89Bio readies equity offering89Bio readies equity offering
seekingalpha.com - September 15 at 8:22 AM
MRNS Catches Eye, SAVA Soars On Alzheimers Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMUMRNS Catches Eye, SAVA Soars On Alzheimer's Study, ETNB Abuzz Over NASH Trial, GILD Snaps Up IMMU
nasdaq.com - September 15 at 3:21 AM
89Bio readies public offering89Bio readies public offering
seekingalpha.com - September 14 at 10:21 PM
89bios lead drug shows positive effect in NASH study89bio's lead drug shows positive effect in NASH study
seekingalpha.com - September 14 at 12:21 PM
89bio (NASDAQ:ETNB) Shares Gap Up to $34.5689bio (NASDAQ:ETNB) Shares Gap Up to $34.56
americanbankingnews.com - September 14 at 11:43 AM
89bio Announces Positive Topline Results from its Phase 1b/2a Trial of BIO89-100 in NASH89bio Announces Positive Topline Results from its Phase 1b/2a Trial of BIO89-100 in NASH
finance.yahoo.com - September 14 at 7:20 AM
89bio to Announce Topline Results from Phase 1b/2a Study of BIO89-100 in NASH89bio to Announce Topline Results from Phase 1b/2a Study of BIO89-100 in NASH
feeds.benzinga.com - September 13 at 8:27 PM
89bio (NASDAQ:ETNB) Shares Gap Up to $37.2489bio (NASDAQ:ETNB) Shares Gap Up to $37.24
americanbankingnews.com - September 4 at 12:49 PM
Critical Comparison: 89bio (NASDAQ:ETNB) vs. Akari Therapeutics (NASDAQ:AKTX)Critical Comparison: 89bio (NASDAQ:ETNB) vs. Akari Therapeutics (NASDAQ:AKTX)
americanbankingnews.com - September 4 at 6:57 AM
89bio Initiates Phase 2 Trial of BIO89-100 in Patients with Severe Hypertriglyceridemia89bio Initiates Phase 2 Trial of BIO89-100 in Patients with Severe Hypertriglyceridemia
finance.yahoo.com - September 3 at 12:24 PM
89bio EPS misses by $0.0589bio EPS misses by $0.05
seekingalpha.com - August 13 at 7:32 PM
89bio Reports Second Quarter 2020 Financial Results and Provides Corporate Update89bio Reports Second Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - August 13 at 7:32 PM
Why Earnings Season Could Be Great for 89bio (ETNB)Why Earnings Season Could Be Great for 89bio (ETNB)
finance.yahoo.com - August 11 at 4:39 PM
How Much Of 89bio, Inc. (NASDAQ:ETNB) Do Institutions Own?How Much Of 89bio, Inc. (NASDAQ:ETNB) Do Institutions Own?
finance.yahoo.com - August 10 at 2:55 PM
89bio raises $83.8M in stock offering89bio raises $83.8M in stock offering
seekingalpha.com - July 13 at 12:46 PM
89bio Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares89bio Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - July 13 at 12:46 PM
89bio (ETNB) Jumps: Stock Rises 6.9%89bio (ETNB) Jumps: Stock Rises 6.9%
finance.yahoo.com - July 10 at 9:32 AM
89bio prices equity offering at $27.5089bio prices equity offering at $27.50
seekingalpha.com - July 8 at 9:15 AM
89bio Announces Pricing of Upsized Public Offering of Common Stock89bio Announces Pricing of Upsized Public Offering of Common Stock
finance.yahoo.com - July 7 at 11:57 PM
89bio launches equity offering89bio launches equity offering
seekingalpha.com - July 6 at 9:19 AM
89bio Announces Proposed Public Offering of Common Stock89bio Announces Proposed Public Offering of Common Stock
finance.yahoo.com - July 6 at 9:19 AM
Hedge Funds Dumped 89bio, Inc. (ETNB) During The CrashHedge Funds Dumped 89bio, Inc. (ETNB) During The Crash
finance.yahoo.com - May 27 at 7:25 PM
89bio Reports First Quarter 2020 Financial Results and Provides Corporate Update89bio Reports First Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - May 13 at 8:58 PM
89bio to Present at Upcoming Investor Conferences89bio to Present at Upcoming Investor Conferences
finance.yahoo.com - May 8 at 4:49 PM
89bio closes enrollment in study of lead drug in NASH89bio closes enrollment in study of lead drug in NASH
seekingalpha.com - April 13 at 4:26 PM
89bio Announces Closing of Enrollment in its Phase 1b/2a NASH Trial and Reports New Preclinical Data Confirming BIO89-100’s Mechanism of Action Via Potent FGF Receptor Agonism89bio Announces Closing of Enrollment in its Phase 1b/2a NASH Trial and Reports New Preclinical Data Confirming BIO89-100’s Mechanism of Action Via Potent FGF Receptor Agonism
finance.yahoo.com - April 13 at 4:26 PM
89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors89bio Appoints Healthcare Industry Veteran Steven Altschuler, M.D., as Chairman of the Board of Directors
finance.yahoo.com - March 25 at 6:22 PM
89bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update89bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 18 at 5:34 PM
89bio reports Q4 results89bio reports Q4 results
seekingalpha.com - March 18 at 4:15 PM
89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference
finance.yahoo.com - February 21 at 4:34 PM
Will 89bio (NASDAQ:ETNB) Spend Its Cash Wisely?Will 89bio (NASDAQ:ETNB) Spend Its Cash Wisely?
finance.yahoo.com - February 11 at 7:24 AM
89bio Inc.89bio Inc.
www.barrons.com - January 24 at 10:32 PM
89bio Reports Third Quarter 2019 Financial Results and Provides Corporate Update89bio Reports Third Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - December 18 at 5:58 PM
U.S. IPO Weekly Recap: NASH Biotech Jumps 69% As Multi-Billion Dollar Companies Join The PipelineU.S. IPO Weekly Recap: NASH Biotech Jumps 69% As Multi-Billion Dollar Companies Join The Pipeline
seekingalpha.com - November 16 at 1:10 PM
89bio Announces Pricing of Upsized Initial Public Offering89bio Announces Pricing of Upsized Initial Public Offering
finance.yahoo.com - November 15 at 4:36 PM
89bio Announces Presentations of BIO89-100 Data at The Liver Meeting® 201989bio Announces Presentations of BIO89-100 Data at The Liver Meeting® 2019
finance.yahoo.com - November 15 at 4:36 PM
89bio Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares89bio Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - November 15 at 4:36 PM
This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.